Sector ratings Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.87 USD | -0.71% |
|
+2.93% | +15.74% |
| Jul. 29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.12B | AA | |||||||
| 48.22B | AAA | |||||||
| 38.79B | - | B | - | - | ||||
| 38.41B | AAA | |||||||
| 34.88B | - | |||||||
| 29.19B | A | |||||||
| 16B | BBB | |||||||
| 16.05B | - | - | - | - | ||||
| 13.53B | AA | |||||||
| 12.22B | AAA | |||||||
| 11.24B | AA | |||||||
| 10.64B | - | BBB | - | - | ||||
| 10.07B | - | B | - | - | ||||
| 8.92B | AA | |||||||
| 8.51B | BB | - | ||||||
| 9.06B | - | A | - | - | ||||
| 8.52B | - | B | - | - | ||||
| 8.75B | AAA | |||||||
| 8.25B | - | BBB | - | - | ||||
| 8.38B | - | BB | - | - | - | - | ||
| Average | 17.54B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
